A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Case Medical Research ◽

10.31525/ct1-nct03900429 ◽

2019 ◽

Author(s):

Keyword(s):

Efficacy And Safety ◽

Download Full-text

A double-blind, randomized, placebo-controlled phase 3 study to assess the efficacy and safety of relacorilant, a selective glucocorticoid receptor modulator, in patients with hypercortisolism due to cortisol-secreting adrenal adenoma(s)/hyperplasia

Endocrine Abstracts ◽

10.1530/endoabs.70.aep17 ◽

2020 ◽

Author(s):

Iacopo Chiodini ◽

Andreas Grauer ◽

Andreas Moraitis ◽

Massimo Terzolo

Keyword(s):

Glucocorticoid Receptor ◽

Adrenal Adenoma ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Receptor Modulator

Download Full-text

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.25 ◽

2019 ◽

Vol 3 ◽

pp. S25

Author(s):

Benjamin Ehst ◽

George Han ◽

Scott Guenthner ◽

Kimberly Eads ◽

Abby Jacobson

Keyword(s):

Disease Duration ◽

Efficacy And Safety ◽

Phase 3 ◽

Two Phase ◽

Abstract not available.

Download Full-text

The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.48 ◽

2017 ◽

Vol 1 ◽

pp. s49

Author(s):

Linda Stein Gold ◽

Sunil Dhawan ◽

Jonathan Weiss ◽

Zoe D Draelos ◽

Herman Ellman

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase 2 ◽

Efficacy And Safety ◽

Abstract Not Available

Download Full-text

Efficacy and safety outcomes in patients with probable or proven versus possible invasive mould disease from the phase 3 secure study, evaluating isavuconazole versus voriconazole for the primary treatment of invasive fungal disease caused by Aspergillus spp. or other filamentous fungi

10.26226/morressier.56d5ba24d462b80296c949e9 ◽

2016 ◽

Author(s):

Johan Maertens

Keyword(s):

Filamentous Fungi ◽

Invasive Fungal Disease ◽

Primary Treatment ◽

Fungal Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Safety Outcomes

Download Full-text

Efficacy and safety of the novel 1L PEG and ascorbate bowel preparation NER1006 versus standard 2L PEG with ascorbate in overnight or morning split-dosing administration: Results from the phase 3 study MORA

10.26226/morressier.57c5383bd462b80296c9c377 ◽

2016 ◽

Author(s):

Raf Bisschops

Keyword(s):

Bowel Preparation ◽

The Novel ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

Efficacy and safety of the novel 1L PEG and ascorbate bowel preparation NER1006 versus sodium picosulfate + magnesium citrate in day before split-dosing administration: Results from the phase 3 study DAYB

10.26226/morressier.57c53840d462b80296c9c40d ◽

2016 ◽

Author(s):

Stefan Schreiber

Keyword(s):

Bowel Preparation ◽

The Novel ◽

Efficacy And Safety ◽

Magnesium Citrate ◽

Phase 3 ◽

Sodium Picosulfate ◽

Download Full-text

MP-AzeFlu for management of allergic rhinitis symptoms in patients >=65 years: A post hoc efficacy and safety analysis from three pooled phase 3 trials

10.26226/morressier.5acc8ad3d462b8028d89adf7 ◽

2018 ◽

Author(s):

Jean Bousquet

Keyword(s):

Allergic Rhinitis ◽

Safety Analysis ◽

Efficacy And Safety ◽

Phase 3 ◽

Download Full-text

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain.

Case Medical Research ◽

10.31525/ct1-nct03992846 ◽

2019 ◽

Author(s):

Keyword(s):

Efficacy And Safety ◽

Download Full-text

The INVIGORATE Trial: A Randomized, Double-masked, Crossover Design, Phase 3 Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

Case Medical Research ◽

10.31525/ct1-nct04207736 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Allergic Conjunctivitis ◽

Crossover Design ◽

Design Phase ◽

Efficacy And Safety ◽

Phase 3 ◽

Seasonal Allergic Conjunctivitis

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text